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Abstract 
 A ten-week stock simulation was conducted to learn basic investment principles, 
perform quantitative analyses, explore qualitative analyses on investment securities, and 
gain real world experience with common investment techniques and investment vehicles.  
Research was performed to identify investment styles that would maximize profits while 
minimizing risk.  Topics examined included sector research, company profitability, P/E 
comparisons to accepted standards, effects of investor impressions, and the effect of 
seasonal conditions on specific sectors.  
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Chapter 1    Introduction 
 
1.1 Goals & Plan of Actions 
 The objective of this project is to better understand the stock market.  It will be 
broken down into four major goals.  Loosely these can be categorized as initial research, 
quantitative analysis, real world experience, and post investment evaluation. 
 The first goal is to build a general knowledge of the stock market, investment 
securities, security trading, and develop a comprehensive list of investment terms and 
acronym definitions.  Additionally there will be an immersion into ongoing financial 
events.  Knowledge of the different trading platforms for different securities will be 
explored including a step by step process of what transpires during a market trade.  This 
goal will be accomplished through research on the internet, reading financial newspapers 
and watching financial news, and will be ongoing throughout the entire course of this 
project. 
 The second goal is to learn and to gain confidence with various quantitative 
analyses as well as to ascertain the generally accepted accuracy of these techniques.  
Techniques of note will be highlighted and explored further with tests during goal three.  
This goal will require further research from all available sources as well as research of 
specific companies' financial records.  To simplify matters I first will target my research 
on the Healthcare sector.  After building up a confidence of expected trends within the 
Healthcare sector I will branch into other sectors. 
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 The third goal is to gain real world experience with different techniques.  Four 
accounts have been set up on an online simulated stock market program.  Two will focus 
on short term trading, one solely within the Healthcare Sector and one not limited to a 
single sector.  The goal of these accounts will be to locate stocks that are trading below 
their true market value according to the price to earnings ratio.  Stocks will also be 
selected based on their current trading price in relation to their 52 week range.  The 
Healthcare Sector has been highlighted as its high volatility can be a boon when buying 
and selling frequently.  From research it has been determined that investors often 
overreact to poor news therefore companies with recent negative events will be targeted.  
Two other accounts will focus on long term trading strategies.  One long term accounts 
will examine mutual funds and the other long term account will be limited to individual 
stocks.  These accounts will look to invest in industries expected to grow during the next 
three months (any larger time is infeasible for this project).  Research has shown that 
energy stocks, specifically gasoline based companies, show increased profits over the 
summer months.  Therefore, these accounts will hold 2-3 stocks (or mutual funds) 
primarily in the energy sector. 
 The fourth goal is to analyze the results of different investing practices utilized in 
goal three.  In order to achieve a realistic baseline, two passive accounts have been set up.  
From research it appears there are two commonly used instruments for comparison to 
match or beat.  The first is the safest investment vehicle, US Treasury Bonds.  The 
second is a stock that matches the market average.  I've selected an index stock of the 
Standard & Poors 500.  The US Treasury account will hold only US Treasury Bills (91 
days to cover the project length), and the market average account will hold shares of 
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Vanguard's S&P 500 Index stock.  Performance of the actively traded accounts will be 
benchmarked against these two passive accounts. 
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Chapter 2 Research 
 
2.1 General Stock Market Research 
The first question many people have when learning of the stock market is "Why 
would someone want to invest their hard earned money in the stock market?"  A simple 
answer to that question is "because that's where the money is."  Research and trends have 
concluded that money has the potential to grow faster when invested than when it is 
socked away in a bank, or worse, stored under the mattress.  Research has also brought to 
light an interesting fact.  The wealthiest individuals do not earn their money from the toils 
of their own labor, but from their investment securities.  And what exactly are investment 
securities?  They are primarily stocks and bonds (although other investment vehicles 
exist).  Simply put stocks represent an ownership in a company, and bonds are a loan to a 
company.  This brings us to our next topic:  the stock market. 
Mentions of the stock market evokes images of people clustered around on a floor 
shouting “Buy!” and “Sell!” while making obscure hand signals and writing on little 
sheets of paper.  While the stock market has changed with the advent of the internet 
(although the New York Stock Exchange still utilizes physical contact) the basic concept 
still remains the same.  In real terms, buys and sells are not initiated solely by the 
customers themselves.  Stocks are bought and sold in an exchange (also called a market), 
through a brokerage, with each playing their own special part.  Exchanges exist to 
facilitate trading by creating a forum where buyers and sellers can meet.  In return for this 
service they take a nominal fee (known as the spread).  The brokerage mediates on behalf 
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of the buyer or seller with the exchange, organizes (brokers) the trade, and informs the 
customer of the result.  For their role the brokerage also takes a fee [1].  Both electronic 
based exchanges (NASDAQ) and in-person exchanges (NYSE) operate on these 
principals. 
At its core security trading and ownership is a way for people to take their wealth 
and make more of it.  But it is also a gamble.  The standard model of security trading 
works on the principal of risk versus reward.  The higher the risk the greater the potential 
for rewards and the greater the chance of loss.  While some concepts and strategies can 
be used to mitigate risks, risks will always be present.  Commonly the first step in 
investment trading is to determine what level of risk you are comfortable with.  Bonds are 
generally considered safer than stocks.  This is due to the fact that if a company has to 
shut down, the bond holders have the first shot at getting their money back while general 
stock holders are paid after everyone else (of course there are some exceptions to the 
rule).  This brings up the first baseline commonly used in investment practices.  The 
safest investment is with the United States of America.  It is generally accepted that the 
US government will still exist when the bond’s amount is due, and that the government 
will be capable of repaying the debt.  As such this group of securities is considered the 
least risky investment and is commonly used as a minimum to how well your investment 
can perform.  Stocks on the other hand have the greatest chance of loosing their value but 
they also can return the highest gain.  One must decide for themselves how much risk 
they can tolerate. 
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Much of the reading available online exists in two forms:  general education, and 
beating the market average.  Beating the average brings up a new baseline, namely how 
do you determine how well the market is performing.  One method of determining how 
well a market is doing is to compare it to other similar markets.  If the stocks in the US 
market increase in value and the stocks in Japan market decrease in value, then you can 
say the US market is doing better than the Japan market.  Similarly, since currency is a 
direct valuation of purchasing power, you can compare the relative strength of each 
nation's currency.  An increase in a currency's valuation results in the ability to buy more 
things (primarily, although there can be other reasons), and therefore a strengthening of 
the economy.  However, there are many variables that can affect different nations' 
economies, which often makes a purely global comparison difficult or misleading.  And 
as our companies become more and more global, these numbers have less significance.  
A more simple evaluation is to select a series of individual stocks that one feels 
represents the economy as a whole.  Several such selections have been set up and are 
called indices.  An index is created when a group selects stocks it feels properly 
represents the market (or a subset of the market) and adds the current selling price of 
these stocks to get a single value.  Therefore, market performance can be gauge by how 
this conglomerate number changes.  One example of an index is the Standard & Poors 
500.  Another example that just about everyone is familiar with is the Dow Jones 
Industrial Average.  When gauging how well your stock is performing against the 
average it is common to compare your stock to the S&P 500 or the Dow. 
 One important thing to remember with stock trading is that these are all real live 
human beings.  Furthermore there exists a small number of big volume and big money 
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traders that often control a very large portion of the market.  Despite their experience and 
responsibilities, these people are still human beings and are subject to human emotions 
and reactions.  Furthermore, these people are often under the stress of putting up large 
numbers and outperforming the market average.  Therefore as the market gets tighter 
their stress increases, and the chance of an overreaction to an insignificant event grows.  
While it is known to be very difficult to associate a quantifiable number to a human 
emotion, several methods have been tried.  One method that has had reasonable success 
of measuring the average consumer's view of the market is the Consumer Confidence 
Index (CCI).  This index attempts to gauge how confident the average person is in the 
market's continuing ability to perform.   
One more thing to remember is that investing is similar to betting on certain 
companies to perform well.  And the primary goal of any company is to be profitable.  
Therefore, especially in long term investing, a profitable company will have a better 
chance of performing better than an unprofitable company.  Often investment advisors go 
one step further.  They encourage people to invest in companies that make sense.  Simple, 
almost common sense predictions can lead towards very profitable sectors and 
companies.  For example, if you find that the world’s population is drastically increasing, 
it would be reasonable to assume that more food would be needed in the world.  
Therefore, investing in companies that produce food could be profitable.  Inventions that 
markedly improve the quality of life tend to make a company very profitable.  The key 
concept here is that there are predictable indicators that exist all around us that can be 
used to find that next hot sector or company. 
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 Finally, research has shown that while there are many methods and reasons for 
choosing where and how much of your money, two common ideas stand out in their 
usage.  These are value investing and growth investing.  Value investing is a style of 
investment strategy from the so-called "Graham & Dodd" School.  Followers of this 
style, known as value investors, generally buy companies whose shares appear 
underpriced by some forms of fundamental analysis; these may include shares that are 
trading at, for example, high dividend yields or low price-to-earning or price-to-book 
ratios.  The main proponents of value investing, such as Benjamin Graham and Warren 
Buffett, have argued that the essence of value investing is buying stocks at less than their 
intrinsic value. The discount of the market price to the intrinsic value is what Benjamin 
Graham called the "margin of safety". The intrinsic value is the discounted value of all 
future distributions.  However, the future distributions and the appropriate discount rate 
can only be assumptions. Warren Buffett has taken the value investing concept even 
further as his thinking has evolved to where for the last 25 years or so his focus has been 
on "finding an outstanding company at a sensible price" rather than generic companies at 
a bargain price [3].  Growth investing is a strategy whereby an investor seeks out stocks 
with what they deem good growth potential. In most cases a growth stock is defined as a 
company whose earnings are expected to grow at an above-average rate than its industry 
or the overall market.  Growth investors often call growth investing a capital growth 
strategy, since investors seek to maximize their capital gains.  Although it is often said 
that growth investing and value investing are diametrically opposed, a better way to view 
these two strategies is to consider a quote by Warren Buffett: "growth and value investing 
are joined at the hip" [4]. 
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2.2 Sector Research 
Initial research was focused on the healthcare sector.  This sector was selected for 
many reasons.  First and foremost a common desire of many people is to live longer and 
better.  Healthcare promises this with its possibilities of preventing and treating ailments.  
And with the retirement of baby boomers in the not too distant future, there will be a 
large segment of the population entering into their later years and soon may be in greater 
need for healthcare.  As an added bonus there is a large amount of speculation in this 
area.  Past research has shown that this sector is highly prone to large gains and losses in 
relatively short time periods.  The Major Drug Manufacturer and Biotechnology sub-
sectors were selected to reduce the overall scope of the project.  Two hundred eighty 
companies selected from Yahoo!® Finance’s indices for these subgroups.  Initial 
evaluation was geared towards identifying average earnings per share in the hope that 
EPS could be used to locate undervalued stocks.  Unfortunately 86% of the companies 
posted losses as of their most recent earning statements.   It was decided that EPS could 
not be used to solely identify undervalued stocks.  The group was reevaluated based on 
EBITDA, EPS, relation to their 52 week low, and having market capitalizations over 
$150 million.  40 of these stocks will be selected for closer examination and will be 
considered for the short term trading accounts.  As a final added bonus, the biotechnology 
industry was hit very hard during the subprime housing crisis that struck prior to this 
project in February 2007. 
 Secondary research proceeded on the energy sector, specifically in the Oil & Gas 
subgroups.  It is a widely held theory that gas prices increase over the summer months 
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[5], leading to greater profits for gasoline refiners, purifiers, and distributors.  Combined 
with the continuing disturbance in the Middle East it appears that gas production related 
stocks will do well during the course of this IQP (the next 3 months). 
 Lastly research was performed in the financial sector.  This sector was hit hard 
during the recent subprime housing “meltdown.”  Furthermore as this project progressed, 
the sector performed increasingly worse as subprime lenders declared bankruptcy and 
prime lenders took a hit.  Once again, this is a large sector so it was narrowed down to the 
following:  Credit Services, Diversified Investments, Money Center Banks, Mortgage 
Investment, Savings & Loans, and Regional banks.  In all 952 companies were selected 
and evaluated.  The average P/E ratios ranged from 16.15x to 31.29x depending on the 
specific industry.  This industry was also doing better on average with over 85% of the 
companies posting a positive EPS (a reverse of the healthcare sub-sectors).  To maintain 
a similar comparison to the healthcare account, stocks will be selected that have near 52 
week lows and a market capitalization over $150 million.   
 
2.3 Understanding Company Financials 
 Understanding company financials is a key part to determining if a company is a 
solid investment.  Even if the company has the best ideas in the world, if it cannot create 
a profit it is doomed to fail and will take your money with it.  Luckily all public 
companies must submit a series of reports to the Securities Exchange Commission (SEC) 
which includes their key financial data.  These forms can be submitted yearly (like the 
Annual Report and Form 10K) or quarterly (like the Form 10Q).  These forms are 
 11
designed to give guidance as to how a company has been performing in the past and often 
times what they expect for the future.  Within these forms are 3 very special statements:  
the Balance Sheet, the Income Statement, and the Cash Flow Statement.  Together these 
three statements provide a snapshot of a company's financial situation.  Understanding 
each of these items is the key to understanding a company's profitability and can give 
some insight into how well a company can weather future hardships. 
Balance Sheet 
 The Balance Sheet, among other things, shows you the value of the assets the 
company owns, the amount of debt, how much inventory is in the corporate warehouse, 
and how much money the business has to work with in the short term [6].  The structure 
of the Balance Sheet is broken into 3 major areas:  Assets, Liabilities and Shareholder 
Equity.  Every balance sheet must "balance".  This means that the total value of all assets 
must be equal to the combined value of the all liabilities and shareholder equity.  Assets 
and Liabilites are broken down into Current and Long Term.  Current applies to items 
that can be turned into cash or will be owed in a short period of time (usually within a 
year or less) [6].  Short term assets are important to review because these are the funds 
the company has available to pay for it's day to day operations.  Comparing short term 
assets and short term liabilities, a term called Working Capital, lets us know if the 
company can financially survive in the near term or if loans will be needed to sustain the 
company.  Long term Assets and Liabilties primarily applies to items that are held longer 
than one year and therefore can not be used to fund day to day operations. 
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 Within the Current Assets grouping you have several common lines and 
sometimes a few lines used in special circumstances.  Primarily there are Cash and Cash 
Equivalents, Short Term Investments, Receivables, Inventories, and Prepaid Expenses.  
Cash and Cash Equivalents is the amount of money the company has in bank accounts, 
savings bonds, certificates of deposit, and money market funds.  Short Term Investments 
are investments that the company plans to sell shortly or can be sold to provide cash.  
Short term investments aren't as readily available as money in a checking account, but 
they provide added cushion if some immediate need were to arise [8].  Receivables are 
money that is owed to the company by its customers for inventory sold or services 
performed [9].  Inventory consists of merchandise a business owns but has not sold.  It is 
classified as current assets because investors assume that inventory can be sold in the 
near future, turning it into cash [10].  Prepaid expenses are exactly what you would 
expect them to be, namely future expected expenses (like rent or utility bills) that the 
company paid before it was due.  Other possible line items do exist, however they occur 
with much less frequency than the five already listed. 
 Current Liabilities are made up of Accounts Payable, Accrued Benefits/Payroll, 
Short Term and Current Long Term Debt, and Other Liabilities.  As with Current Assets, 
some nonstandard line items can also exist however the listed categories are common on 
all Balance Sheets.  Accounts Payable occurs when the company receives a product or 
service before the company pays for it.  Accrued Benefits/Payroll is money owed to 
employees as salary and bonuses that the company has not yet paid.  Short Term and 
Current Long Term Debt, also referred to as Notes Payable, are most often bank loans.  
Depending on the company, you will see various other current liabilities listed.  
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Normally, you can find a detailed listing of what these Other Liabilities are buried 
somewhere in the annual report or 10k [11].   
 Long Term Assets are broken down into Long Term Investments, Property, Plant 
and Equipment, Intangible Assets, Goodwill, and Other Assets.  Long Term Investments 
are investments the company intends to hold for more than one year.  They can consist of 
stocks and bonds of other companies, real estate, and cash that have been set aside for a 
specific purpose or project.  In addition to investments a company plans to hold for an 
extended period of time, Long Term Investments also consist of the stock in a company's 
affiliates and subsidiaries [12].  Property, Plant and Equipment, also referred to as fixed 
assets, are the corporation's real estate, buildings, office furniture, telephones, cafeteria 
trays, brooms, factories, etc.  They are the physical assets the company owns but can't 
quickly convert to cash [13].  Intangible Assets are things of value that cannot be 
touched, felt, or seen.  These consist of patents, trademarks, brand names, and franchises 
[14].  Goodwill, in the accounting sense, can be thought of as a "premium" for buying a 
business [15].  Other Assets are as the name implies, various long term unaccounted for 
assets held for more than a year.   
 Long Term Liabilites is often separated into Long Term Debt, Minority Interest 
and Other Liabilities.  Long Term Debt is a crucial figure that refers to the money the 
company owes and doesn't expect to pay off in the next year.  Long term debt consists of 
things such as mortgages on corporate buildings and / or land, as well as business loans 
[16].  Minority Interest refers to the equity of the minority shareholders in a company's 
subsidiaries.  Like the few "other" parts of the balance sheet, Other Liabilities is a catch-
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all category where companies can consolidate their miscellaneous debt.  You can 
normally find an explanation of what makes up these other liabilities somewhere in the 
financial reports [17]. 
 The final part of a Balance Sheet is the Shareholder Equity.  Shareholder Equity is 
the net worth of a company.  It represents the stockholders' claim to a business's assets 
after all creditors and debts have been paid.  Shareholder equity is also referred to as 
Owner's or Stockholders' Equity.  It can be calculated by taking the total assets and 
subtracting the total liabilities [18].  Shareholder equity usually comes from two places.  
The first is cash paid in by investors when the company sold stock; the second is retained 
earnings, which are the accumulated profits a business has held on to and not paid out to 
its shareholders as dividends.  Because these are the two ways a company generally 
creates shareholders' equity, the balance sheet is organized to show each part's 
contribution [18]. 
 Shareholder Equity is made up of Common and Preferred Stock, Capital Surplus, 
Treasury Stock, Retained Earnings, and Other Stockholder Equity.  Common and 
Preferred Stock reflect the par value of the company's stock and / or when there is no par 
value assigned to the stock, the amount investors paid when the company issued shares 
[19].  Capital Surplus is the difference between the total par value of the stock 
outstanding and the shareholder equity and Proprietorship Reserves.  Treasury Stock is 
shares a company has issued and somehow reacquired either through share repurchase 
programs or donations [20].  Retained Earnings are earnings that have been kept by the 
company (as opposed to being issued through a dividend) for reinvestment into the 
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company.  Once again, Other Stockholder Equity is a catchall phrase for anything that 
wasn't already covered. 
 
Income Statement 
 The Income Statement is a collection of line items that sum up the company's 
revenues, expenses, and their end result on the company stock over a specified time 
period.  Income Statements provide a quick overview of how well a company is 
performing.  However, Income Statement analysis can reveal much more than a 
company's earnings. It provides important insights into how effectively management is 
controlling expenses, the amount of interest income and expense, and the taxes paid.  
Investors can use income statement analysis to calculate financial ratios that will reveal 
the rate of return the business is earning on the shareholders' retained earnings and assets; 
they can also compare a company's profits to its competitors by examining various profit 
margins such as the gross profit margin, operating profit margin, and net profit margin 
[21].  The Income Statement can loosely be thought of as attempting to reach 5 different 
values:  Profit, Operating Profit, Net Income from Continuing Operations, Net Income, 
and Net Income Applicable to Common Shares.  It should be noted that companies often 
use different terminology for same concept.  I will try to stay consistent with my usage. 
 The Gross Profit section contains Total Revenues, Cost of Goods Sold, and Gross 
Profit.  The first line on any income statement is the entry for Total Revenue.  This figure 
is the amount of money a business brought in during the time period covered by the 
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income statement [22].  Cost of Goods Sold is the expense a company incurred in order 
to manufacture, create, or sell a product.  It includes the purchase price of the raw 
material as well as the expenses of turning it into a product.  Finally, Gross Profit is the 
total revenue subtracted by the cost of generating that revenue. It tells you how much 
money a business would have made if it didn’t pay any other expenses such as salary, 
income taxes, etc [23] 
 The next section, Operating Profit, focuses on the operating expenses that arise 
during the ordinary course of running a business.  Operating expense consists of 
Employee Salaries, Research and Development Costs, and Other Miscellaneous Charges 
that must be subtracted from the company’s income [24].  Employee Salaries, also listed 
as Selling, General, and Administrative Expenses, consist of the combined payroll costs 
(salaries, commissions, and travel expenses of executives, sales people and employees), 
and advertising expenses a company incurs.  Research and Development Costs are 
expenses from nonproduct development.  Other Miscellaneous Charges can include such 
things as Goodwill and other intangible asset amortization charges.  Finally Operating 
Profit is derived from subtracting all of the operating expenses from the gross profit.  
This can be used to gauge the general health of the core business.   
 Net Income from Continuing Operations contains several key items in it.  Interest 
Expense and Income, Depreciation, Income Tax, and Minority Interest all exist in this 
section.  Interest Income and Expense is interest owed to or paid by the company for 
outstanding loans and investments.  Depreciation is the process by which a company 
gradually records the loss in value of a fixed asset. The purpose of recording depreciation 
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as an expense over a period is to spread the initial purchase price of the fixed asset over 
its useful life [25].  Income Tax is the total amount paid by the company to the 
government.  Minority Interest is profit gained from owning shares of stock in another 
company that posts profits.   Net Income from Continuing Operations is obtained by 
subtracting each of these key items from the Operating Profit. 
 Finally, we derive the Net Income.  Net Income is the total profit made by a 
business before any required dividend payments on the company's preferred stock.  We 
obtain this value by subtracting nonregular expenses from the Net Income from 
Continuing Operations. There are a wide variety of these expenses and a wide variety of 
reasons for there existence.  The Annual Report should give some guidance for the reason 
of their application. 
 The final section, Net Income Applicable to Common Shares, determines the final 
effect on the common stock.  It is derived from subtracting the Preferred Stock Dividend 
from the Net Income.  Preferred stock is a mix between common stock and a bond. Each 
share of preferred stock is normally paid a guaranteed, relatively high dividend and has 
first dibs over common stock at the company's assets in the event of bankruptcy. In 
exchange for the higher income and safety, preferred shareholders miss out on large 
potential capital gains (or losses) [26].  With the Preferred Stock Dividend removed, we 
are now left with the Net Income Applicable to Common Shares.  This is the bottom line 
of the company.  This number divided by the total number of shares outstanding yield the 
Earnings per Share. 
Cash Flow Statement 
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 The Cash Flow Statement is exactly as the name implies the movement of cash 
into and out of the company.  By itself the Cash Flow Statement cannot tell you if a 
business is thriving or barely surviving.  However, all businesses need cash to pay for 
services and any raw materials needed and a business without cash cannot survive for 
very long.  The Cash Flow Statement is organized into three parts.  The first, cash from 
operating activities, can alert one to future declines in sales and earnings by signaling 
when a company is having trouble selling inventory or collecting cash it is owed, among 
other things.  The second, cash from investing activities, gives the reader information on 
how much the company earned in the stock market to whether it's cutting back on capital 
expenditures.  The third part, cash from financing activities, indicates whether a company 
receives cash infusions from outsiders, such as banks or shareholders [28].  While it may 
sound like the Cash Flow Statement would be an exact copy of the Income Statement 
there is a slight difference that is very important.  The Income Statement is based on the 
accrual method of accounting which takes into account noncash items such as property 
while the Cash Flow Statement deals strictly with cash.  
 Cash flow from operating activities measures the cash used or provided by a 
company's normal operations. It shows the company's ability to generate consistently 
positive cash flow from operations. Think of "normal operations" as the core business of 
the company. For example, Microsoft's normal operating activity is selling software [27]. 
 Cash flows from investing activities list all the cash used or provided by the 
purchase and sale of income-producing assets. If Microsoft bought or sold companies for 
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a profit or loss, the resulting figures would be included in this section of the cash flow 
statement [27]. 
 Cash flows from financing activities measure the flow of cash between a firm and 
its owners and creditors. Negative numbers can mean the company is servicing debt but 
can also mean the company is making dividend payments and stock repurchases, which 
investors might be glad to see [27]. 
2.4 Useful Financial Sheet Formulas 
 There are literally thousands of different combinations of values you can derive 
from a business's financial statements.  However, many of these are tell little or no 
information that will be important when making decisions on what constitutes a viable 
investment.  What follows is a selection of a few useful calculations you can perform on 
the Balance Sheet, Income Statement, and Cash Flow Statement.  Unfortunately, to make 
matters complicated, many of these ratios are drastically different between separate 
industries and possibly even within the same industry.  Therefore it is best to use this 
information loosely when comparing to an industry and with the ultimate desire to be 
used for comparison amongst competitors. 
Receivable Turns 
 Common sense tells you the faster a company collects its receivables, the better.  
The sooner customers pay their bills the sooner a company can put the cash in the bank, 
pay down debt, or start making new products.  There is also a smaller chance of losing 
money to delinquent accounts.  Fortunately, there is a way to calculate the number of 
days it takes for a business to collect its receivables.  The formula looks like this: 
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 Using this formula, we can also calculate the Average Age of Receivables.  
Simply divide the number of Receivable Turns by 365.  This gives us an idea of how 
quickly the average receivable is being paid off.  When this is compared to the company's 
average invoice due date time frame we can determine how efficiently the company is 
with bringing in money owed to them. 
Inventory Turns 
 A large number of companies exist by selling a physical product to a customer.  
Before you invest, you are going to have to make an informed decision about how much 
you think the inventory is really worth.  A major part of this decision should be based on 
how fast the inventory is "turned" (or sold).  Two competing companies may each have 
$20 million sitting in inventory, but if one can sell it all every 30 days, and the other takes 
41 days, you have less of a risk of inventory loss with the 30 day company. 
 
 Once again, we can take this formula one setup further and figure out the Number 
of Days for Inventory Turns.  As with the previous formula, we simply divide the 
Inventory Turns by 365.  This tells us on average how many days it takes to sell the entire 
inventory. 
Inventory to Current Assets Ratio 
 When analyzing a balance sheet, you also want to look at the percentage of 
current assets inventory represents.  If 70% of a company's current assets are tied up in 
Cost of Goods Sold 
Average Inventory 
Inventory Turns = 
Credit Sales 
Average Receivables 
Receivable Turns = 
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inventory and the business does not have a relatively low turn rate (less than 30 days), it 
may be a signal that something is seriously wrong and an inventory write-down is 
unavoidable [29]. 
 
Working Capital 
 Arguably the number one reason most people look at a balance sheet is to find out 
a company's working capital (or "current") position.  It reveals more about the financial 
condition of a business than almost any other calculation.  It tells you what would be left 
if a company raised all of its short term resources, and used them to pay off its short term 
liabilities.  The more working capital, the less financial strain a company experiences 
[30]. 
 
 A company that makes heavy machinery and a grocer will have completely 
varying Working Capital amounts and suffer from different sources of risk.  Because the 
heavy machinery manufacturer is selling expensive items on a long-term payment basis, 
they can't raise cash as quickly.  Since the inventory on their balance sheet is normally 
ordered months in advance, it can rarely be sold fast enough to raise money for short-
term financial crises (by the time it is sold, it may be too late).  It's easy to see why 
companies such as this must keep enough working capital on hand to get through any 
unforeseen difficulties [30].  You can, as usual, determine a guideline depending on how 
Working Capital = Current Assets - Current Liabilities 
Average Inventory 
Current Assets 
Inventory to Current 
Assets Ratio = 
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a company's competitors operate.  This brings us to our next formula, Working Capital 
per Dollar of Sales.   
 
Current Ratio 
 The current ratio is another test of a company's financial strength.  It calculates 
how many dollars in assets are likely to be converted to cash within one year in order to 
pay debts that come due during the same year [31].  This ratio is useful when determing if 
a company will be required to take on more long term debt or sell long term assets to 
survive during the next 12 months. 
 
 
Quick Test Ratio 
 The Quick Test Ratio (also called the Acid Test or Liquidity Ratio) is the most 
excessive and difficult test of a company's financial strength and liquidity.  It compares 
the amount of cash you have immediately available to your current liabilities.  This test is 
useful in determining if a company can survive the upcoming year without selling any 
inventory. 
 
Debt to Equity Ratio 
Current Assets - Inventory 
Current Liabilities 
Quick Test Ratio = 
Current Assets 
Current Liabilities 
Current Ratio = 
Working Capital 
Total Sales 
Working Capital per 
Dollar of Sales = 
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 The Debt to Equity Ratio measures how much money a company should safely be 
able to borrow over long periods of time.  It does this by comparing the company's total 
debt (including short term and long term obligations) to the company's equity.  This ratio 
is useful in determing if a company has taken out too many loans while building little 
assets. 
 
Gross Profit Margin 
 Gross Profit Margin is a measurement of a company’s manufacturing and 
distribution efficiency during the production process. The gross profit tells an investor the 
percentage of revenue / sales left after subtracting the cost of goods sold.  A company 
that boasts a higher gross profit margin than its competitors and industry is more 
efficient. Investors tend to pay more for businesses that have higher efficiency ratings 
than their competitors, as these businesses should be able to make a decent profit as long 
as overhead costs are controlled (overhead refers to rent, utilities, etc) [32]. 
 
Operating Margin 
 The operating margin is another measurement of management’s efficiency. It 
compares the quality of a company’s operations to its competitors. A business that has a 
higher operating margin than its industry’s average tends to have lower fixed costs and a 
better gross margin, which gives management more flexibility in determining prices. This 
pricing flexibility provides an added measure of safety during tough economic times [33]. 
Gross Profit 
Total Revenue 
Gross Profit Margin = 
Total Assets 
Total Liabilities 
Debt to Equity Ratio = 
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Interest Coverage Ratio 
 The interest coverage ratio is a measurement of the number of times a company 
could make its interest payments with its earnings before interest and taxes; the lower the 
ratio, the higher the company’s debt burden [34]. 
 
Net Profit Margin 
 The profit margin tells you how much profit a company makes for every $1 it 
generates in revenue. Profit margins vary by industry, but all else being equal, the higher 
a company’s profit margin compared to its competitors, the better off the company is. 
 
Return on Equity 
 Return on equity reveals how much profit a company earned in comparison to the 
total amount of shareholder equity found on the balance sheet.  A business that has a high 
return on equity is more likely to be one that is capable of generating cash internally [34]. 
 
Asset Turnover 
Net Profit 
Avg Shareholder Equity 
Return on Equity = 
Net Income After Taxes 
Total Revenue 
Net Profit Margin = 
Earnings Before Interest & Taxes 
Interest Expense 
Interest Coverage Ratio = 
Operating Income 
Total Revenue 
Operating Margin = 
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 The asset turnover ratio calculates the total sales [revenue] for every dollar of 
assets a company owns. 
 
Return on Assets 
 Where asset turnover tells an investor the total sales for each $1 of assets, return 
on assets [or ROA for short] tells an investor how much profit a company generated for 
each $1 in assets. The return on assets figure is also a sure-fire way to gauge the asset 
intensity of a business [35]. 
 
Operating Cash Flow Ratio 
 A measure of how well current liabilities are covered by the cash flow generated 
from a company's operations [2]. 
 
 
2.5 Specific Company Research 
Unless otherwise mentioned, descriptions are taken from Yahoo!® Finance page with 
some personal notes added in for my reference. 
Cash Flow from Operations 
Current Liabilities 
Operating Cash 
Flow Ratio = 
Net Income 
Avg Assets for the Period 
Return on Assets  = 
Total Revenue 
Avg Assets for the Period 
Asset Turnover = 
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Affymax Inc (AFFY) 
A biopharmaceutical company, engages in the development of peptide-based drug 
candidates to enhance the treatment of serious and life-threatening conditions.  It’s 
long term 90 day prospects are not good as it is still years away from developing a 
drug.  Earnings loss over the past year has dropped the stock price by 75% as well, 
putting it marginally over its lowest price in the past year.  Short term prospects 
seem hopeful as the healthcare sector continues its recovery. 
Idenix Pharmaceuticals (IDIX) 
A biopharmaceutical company, engages in the discovery, development, and 
commercialization of drugs for the treatment of human viral and other infectious 
diseases in the United States and Europe.  Similar in respects to Affymax Inc.  Poor 
long term prospects, earnings loss and stock price at near 52 week low.   
Osiris Therapeutics, Inc. (OSIR) 
A biotechnology company, commercializes stem cell products from adult bone 
marrow in the United States.  Similar criteria as Affymax Inc. 
Cambrex Corporation (CBM) 
Provides various products and services that enable the development and 
commercialization of branded and generic small molecule therapeutics.  Unlike other 
selected Biotechnology stocks, this stock is actually profitable and produces various 
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active pharmaceutical ingredients.  Poor earnings in May have caused this stock to 
plummet to a very low level. 
BioCryst Pharmaceuticals Inc. (BCRX) 
Engages in the design, optimization, and development of novel drugs that block key 
enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral 
infections.  Sluggish market recovery has made this stock a prime candidate for some 
recovery in the near term. 
Chevron Corp. (CVX) 
Operates as an integrated energy company worldwide.  Overall the energy industry 
has done well in the past few months, and future prospects look good. 
Exxon Mobil Corp. (XOM) 
Engages in the exploration, production, transportation, and sale of crude oil and 
natural gas.  In the recent past Exxon Mobil has posted the largest revenues of any 
public company.  Future plans appear to in the same line. 
PetroChina Co. Ltd. (PTR) 
Together with its subsidiaries, engages in petroleum and natural gas related activities 
in the People’s Republic of China.  With China’s petroleum requirements increasing 
faster than any other nation, oil prices on the rise, and reserves being reduced, oil 
company profit in China appears to be the closest to a “sure thing.” 
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Emergent BioSystems, Inc (EBS) 
A biopharmaceutical company focused on the development, manufacture, and 
commercialization of immunobiotics primarily in the United States.  This has been 
highly undervalued, as it is one of the few profitable biotechs.  Reasons for this 
undervaluation could be a recent missed earnings estimate. 
 
Figure 2.5-1 Emergent BioSolutions Chart 
Genetech Inc (DNA) 
Genentech, Inc. engages in the discovery, development, manufacture, and 
commercialization of biotherapeutics in the United States.  Shares have not 
recovered since the Biotech downturn earlier this year. 
AstraZeneca plc (AZN) 
AstraZeneca PLC discovers, develops, manufactures, and markets prescription 
pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, 
 29
oncology, respiratory and inflammation, and infection worldwide.  Shares of 
AstraZeneca have also not recovered from the recent downturn. 
 
 
Figure 2.5-2 AstraZeneca 1 Year Chart 
Sanofi-Aventis (SNY) 
Sanofi-Aventis engages in the research, development, manufacture, and 
marketing of healthcare products worldwide.  They just released a press release 
stating that their obesity drug has to be pulled from the market.   
Aspreva Pharmaceutical Corp (ASPV) 
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Aspreva Pharmaceuticals Corporation engages in the identification, development, 
and commercialization of approved drugs and drug candidates for new 
indications.  They’ve just been down graded by several analysts after a failed drug 
trial. 
Hancock Holdings Co (HBHC) 
Hancock Holding Company, a financial holding company, provides a range of 
financial and banking products and services in Mississippi, Louisiana, and 
Florida. 
Astoria Financial Corp (AF) 
Astoria Financial Corporation operates as the holding company of Astoria Federal 
Savings and Loan Association that provides various banking services in the 
United States. 
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Figure 2.5-3 Astoria Financial 5 Day Chart 
 
Virginia Commerce Bancorp Inc. (VCBI) 
Virginia Commerce Bancorp, Inc. operates as the holding company for Virginia 
Commerce Bank that provides various business and consumer banking products 
and services. 
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Figure 2.5-4 Virginia Commerce Bancorp 1 Year Chart 
Hudson City Bancorp Inc. (HCBK) 
Hudson City Bancorp operates as the holding company for Hudson City Savings 
Bank, which provides various retail banking services in the states of New Jersey, 
New York, and Connecticut.  Hudson City Bancorp is currently near a 1 year low 
despite posting higher than expected profits from new branches. 
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Figure 2.5-5 Hudson City Bancorp Inc 1 Year Chart 
Keryx Biopharmaceuticals Inc. (KERX) 
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the 
acquisition, development, and commercialization of pharmaceutical products for 
the treatment of diabetes and cancer. 
Trimeris Inc. (TRMS) 
Trimeris, Inc., a biopharmaceutical company, engages in the discovery, 
development, and commercialization of therapeutic agents for the treatment of 
viral disease in the United States and Canada. 
ZymoGenetics, Inc. (ZGEN) 
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ZymoGenetics, Inc. engages in the discovery, development, manufacture, and 
commercialization of therapeutic proteins for the treatment of human diseases in 
the areas of hemostasis, inflammatory and autoimmune diseases, cancer, and viral 
infections. 
 
Figure 2.5-6 ZymoGenetics 1 Year Chart 
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Chapter 3 Application 
 
3.1 Benchmarks 
The benchmark of 91 day US Treasury Bills were purchased on 5/23/2007.  A total 
of 101 bills were purchased.  The bills carried a discount rate of 4.775% and an 
investment rate of 4.914%.  These bills were based off of a recent sale (CUSIP 
912795ZW4) sold on TreasuryDirect.gov.  This bill had the same start period and time 
till completion as this project, and a similar discount and investment rate as other 91 day 
T-bills.  It is believed that this security will represent the minimum alternative when 
comparing security performance. 
The benchmark of Vanguard S&P 500 Index (VFINX) was purchased on 5/23/2007 
at 10:32:10 AM.  710 shares were purchased at $140.67 a share.  It is believed that this 
security will represent the market average. 
All positions were closed out on July 27th, 2007.  Shares of Vanguard S&P Index 
fund ended at $134.49 resulting in a 4.41% loss over the course of the project.  Treasury 
bonds ended with a 0.87% gain over the project. 
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3.2 Short Term Trading 
Short term accounts set up their initial stocks on June 7th, 2007.  The Healthcare 
stock account purchased 2,740 shares of Osiris Therapeutics (OSIR) at $12.14 a share.  
Additional purchases were made on Cambrex Corporation (CBM) of 2,664 shares at 
$12.51 a share and BioCryst Pharmaceuticals Inc of 4,282 shares at $7.78 a share.  The 
Intersector short term account made its initial purchases as well.  Idenix Pharmaceuticals 
(IDIX) was purchased at $7.10 for 7,040 shares and Affymax (AFFY) was purchased at 
$31.69 for 1,657 shares. 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start             $100,000.00 $100,000.00 
6/7/2007 OSIR Buy $12.14 2,740 $33,270.60  $66,729.40 $100,000.00 
6/7/2007 CBM Buy $12.51 2,664 $33,333.64  $33,395.76 $100,000.00 
6/7/2007 BCRX Buy $7.78 4,282 $33,320.96  $74.80 $100,000.00 
Table 3.2-1 Week 3 Healthcare Account 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $100,000.00  $100,000.00 
6/7/2007 IDIX Buy $7.10 7,040 $49,991.00  $50,009.00  $100,000.00 
6/7/2007 AFFY Buy $30.17 1,657 $49,998.69  $10.31  $100,000.00 
Table 3.2-2 Week 3 Intrasector (Finance) Account 
Additional trading occurred in the week ending June 15th, 2007.  2,740 shares of 
Osiris Therapeutics were sold at $12.80 a share (for a 5.4% gain).  The money 
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immediately turned around and was used to purchase 4,070 shares of Emergent 
BioSolutions, Inc at $8.61. 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $74.80 $100,000.00 
6/13/2007 OSIR Sell $12.80 2,740 ($35,065.00) $1,794.40 $35,139.80 $101,794.40 
6/13/2007 EBS Buy $8.61 4,070 $35,049.70  $90.10 $101,794.40 
Table 3.2-3 Week 4 Healthcare Account 
 
More trading occurred during the week of June 22nd, 2007.  4,070 shares of 
Emergent BioSolutions were sold at $10.09 per share (for a 17.15% gain).  This situation 
is a prime example of the potential of locating undervalued stocks, holding for a few 
days, and quickly selling the security off for a profit (see figure below).  2,664 shares of 
Cambrex Corporation were also sold at $13.38 per share (for a 6.91% gain).  The profits 
were plowed into two very well known Biotechs who have been trading sluggish lately.  
512 shares of Genetech were purchased at $74.93 apiece, and 745 shares of AstraZeneca 
plc were purchased at $51.11.  The Intrasector short term trading account was forced to 
take a big hit while dumping shares of Affymetrix (1,657 shares sold at $28.14 for a 
6.76% loss) and Idenix Pharmaceuticals (7,040 shares sold at $6.18 for a 12.98% loss).  
Enough time had been wasted waiting for these stocks to recover to a positive level.  The 
remaining balance was moved into finance stocks IberiaBank Corp (IBKC), Community 
Bancorp (CBON), and Community Trust Bancorp Inc (CTBI).  These stocks have shown 
positive earnings reports, yet are still trading within 10% of 1 year lows (see figure for 
IBKC below).  602 shares of IberiaBank Corp were purchased at $49.87, 1,066 shares of 
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Community Bancorp were purchased at $28.17 and 940 shares of Community Trust 
Bancorp Inc were purchased at $31.74. 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $90.10 $101,794.40 
6/18/2007 EBS Sell $10.09 4,070 ($41,059.30) $6,009.60 $41,149.40 $107,804.00 
6/22/2007 CBM Sell $13.38 2,664 ($35,637.32) $2,303.68 $76,786.72 $110,107.68 
6/22/2007 DNA Buy $74.93 512 $38,371.16  $38,415.56 $110,107.68 
6/22/2007 AZN Buy $51.11 745 $38,083.95  $331.61 $110,107.68 
 
Table 3.2-4 Week 5 Healthcare Account 
 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $10.31  $100,000.00 
6/22/2007 AFFY Sell $28.14 1,657 ($46,620.98) ($3,377.71) $46,631.29  $96,622.29 
6/22/2007 IDIX Sell $6.18 7,040 ($43,500.20) ($6,490.80) $90,131.49  $90,131.49 
6/22/2007 IBKC Buy $49.87 602 $30,028.74  $60,102.75  $90,131.49 
6/22/2007 CBON Buy $28.17 1,066 $30,036.22  $30,066.53  $90,131.49 
6/22/2007 CTBI Buy $31.72 940 $29,823.80  $242.73  $90,131.49 
 
Table 3.2-5 Week 5 Intrasector (Finance) Account 
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Figure 3.2-1 IberiaBank Corp Chart 
 Short term trading was positive for the week of June 29th, 2007.  The healthcare 
account sold shares of Genentech (512 shares sold at $75.49 for a 0.71% gain) and shares 
of AstraZeneca (745 shares sold at $53.54 for a 4.72% gain).  The money was moved into 
Sanofi-Aventis (SNY, 975 shares at $40.29) and Aspreva Pharmaceutical Company 
(ASPV, 2,300 shares at $17.12).  Short term finance trading for the week was mixed.  
Gains were recorded on sales however stocks dipped after purchases resulting in an 
overall loss during the week.  Shares of Community Trust Bancorp (940 shares sold at 
$32.95 for a 3.83% gain) and shares of Community Bancorp (1,066 shares sold at $28.42 
for a 0.84% gain).  The proceeds were moved into Hancock Holding Co (HBHC, 800 
shares at $38.35) and Astoria Financial Corp (AF, 1,220 shares at $25.09). 
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Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $331.61 $110,107.68 
6/29/2007 AZN Sell $53.54 745 ($39,880.30) $1,796.35 $40,211.91 $111,904.03 
6/29/2007 DNA Sell $75.49 512 ($38,643.88) $272.72 $78,855.79 $112,176.75 
6/29/2007 SNY Buy $40.29 975 $39,289.75  $39,566.04 $112,176.75 
6/29/2007 ASPV Buy $17.12 2,300 $39,383.00  $183.04 $112,176.75 
 
Table 3.2-6 Week 6 Healthcare Account 
 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $242.73  $90,131.49 
6/29/2007 CTBI Sell $32.95 940 ($30,966.00) $1,142.20 $31,208.73  $91,273.69 
6/29/2007 CBON Sell $28.42 1,066 ($30,288.72) $252.50 $61,497.45  $91,526.19 
6/29/2007 AF Buy $25.09 1,220 $30,616.80  $30,880.65  $91,526.19 
6/29/2007 HBHC Buy $38.35 800 $30,687.00  $193.65  $91,526.19 
 
Table 3.2-7 Week 6 Intrasector (Finance) Account 
 
Growth in the short term Healthcare sector for the week of July 6th, 2007 was 
positive.  Recent sellings of Aspreva (2,300 shares sold at $18.79 for a 9.72% gain), 
BioCryst Pharmaceuticals (4,282 shares sold at $7.82 for a 0.47% gain) and Sanofi-
Aventis (975 shares sold at $41.82 for a 3.76% gain) netted a 5.07% overall gain.  The 
proceeds were used to purchase shares of Keryx Biopharmaceuticals (KERX, 3,993 
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shares at $9.81), Trimeris Inc (TRMS, 5,979 shares at $6.54), and ZymoGenetics (ZGEN, 
2,760 shares at $14.19).  All are small cap companies near their 52 week low and all 
happen to have changed a chief officer and / or a director recently.  Short term finance 
trading profit was obtained from selling shares of Astoria Financial Corp (1,220 shares 
sold at $25.34 for a 0.95% gain) and shares of IberiaBank Corp (602 shares sold at 
$49.95 for a 0.11% gain).  Proceeds were moved into Virginia Commerce Bancorp Inc 
(VCBI, 1,865 shares at $16.33) and Hudson City Bancorp Inc (HCBK, 2,495 shares at 
$12.24).  These are a mix of small and large cap companies near their 52 week low. 
 
Figure 3.2-2 Aspreva & Sanofi-Aventis 1 Week Gains 
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Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $183.04 $112,176.75  
7/6/2007 ASPV Sell $18.79 2,300 ($43,210.00) $3,827.00 $43,393.04 $116,003.75  
7/6/2007 BCRX Sell $7.82 4,282 ($33,478.24) $157.28 $76,871.28 $116,161.03  
7/6/2007 SNY Sell $41.82 975 ($40,767.50) $1,477.75 $117,638.78 $117,638.78  
7/6/2007 KERX Buy $9.81 3,993 $39,178.33  $78,460.45 $117,638.78  
7/6/2007 TRMS Buy $6.54 5,979 $39,109.66  $39,350.79 $117,638.78  
7/6/2007 ZGEN Buy $14.19 2,760 $39,171.40  $179.39 $117,638.78  
 
Table 3.2-8 Week 7 Healthcare Account 
 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $193.65  $91,526.19 
7/6/2007 AF Sell $25.34 1,220 ($30,907.80) $291.00 $31,101.45  $91,817.19 
7/6/2007 IBKC Sell $49.95 602 ($30,062.90) $34.16 $61,164.35  $91,851.35 
7/6/2007 HCBK Buy $12.24 2,495 $30,545.80  $30,618.55  $91,851.35 
7/6/2007 VCBI Buy $16.33 1,865 $30,462.45  $156.10  $91,851.35 
 
Table 3.2-9 Week 7 Intrasector (Finance) Account 
 Trading in the healthcare sector for the week of July 13th, 2007 was light.  While 
the majority of the market posted gains, the healthcare sector was hit fairly hard.  Never 
the less shares of Trimeris Inc (5,979 shares sold at $6.74 for a 3.01% gain) were sold for 
a positive gain.  No shares were purchased.  No trading in the financial sector occurred.  
The down trodden stocks that were chosen seem to fair worse as the market improved. 
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Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $179.39 $117,638.78 
7/13/2007 TRMS Sell $6.74 5,979 ($40,291.46) $1,181.80 $40,470.85 $118,820.58 
 
Table 3.2-10 Week 8 Healthcare Account 
 Trading within the healthcare sector was heavy for the week ending July 20th, 
2007.  Stocks that had remained negative were closed out, however gains late in the week 
helped offset the losses somewhat.  Shares of Keryx Biopharmaceuticals (3,993 shares 
sold at $9.01 for an 8.15% loss) and ZymoGenetics (2,760 shares sold at $13.96 for a 
1.62% loss) gave the healthcare account its first week posting a loss to date.  Proceeds 
were moved into AstraZeneca (AZN, 696 shares at $55.05), Amgen (AMGM, 690 shares 
at $55.52) and Momenta Pharmaceuticals Inc (MNTA, 3,670 shares at $10.41).  Trading 
in the financial sector was equally heavy.  The account put up slight positive postings 
after sales of Virginia Commerce Bancorp (1,865 shares sold at $17.00 for a 4.10% gain), 
Hancock Holding Co. (800 shares sold at $39.01 for a 1.72% gain) and Hudson City 
Bancorp Inc (2,495 shares sold at $11.69 for a 4.49% loss).  Purchases were made in 
BankAtlantic Bancorp Inc (BBX, 4,060 shares at $7.57), Franklin Bank Corp (FBTX, 
2,300 shares at $13.17) and Webster Financial Corp (WBS, 760 shares at $40.81). 
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Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $40,470.85 $118,820.58 
7/17/2007 KERX Sell $9.01 3,993 ($35,983.93) ($3,194.40) $76,454.78 $115,626.18 
7/17/2007 ZGEN Sell $13.96 2,760 ($38,536.60) ($634.80) $114,991.38 $114,991.38 
7/18/2007 AZN Buy $55.05 696 $38,321.80  $76669.58 $114,991.38 
7/18/2007 AMGN Buy $55.52 690 $38,315.80  $38353.78 $114,991.38 
7/18/2007 MNTA Buy $10.41 3,670 $38,211.70  $142.08 $114,991.38 
 
Table 3.2-11 Week 9 Healthcare Account 
 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $156.10  $91,851.35 
7/18/2007 VCBI Sell $17.00 1,865 ($31,712.00) $1,249.55 $31,868.10 $93,100.90 
7/19/2007 HBHC Sell $39.01 800 ($31,215.00) $528.00 $63,083.10 $93,628.90 
7/19/2007 HCBK Sell $11.69 2,495 ($29,173.55) ($1,372.25) $92,256.65 $92,256.65 
7/20/2007 BBX Buy $7.57 4,060 $30,741.20  $61,515.45 $92,256.65 
7/20/2007 FBTX Buy $13.17 2,300 $30,298.00  $31,217.45 $92,256.65 
7/20/2007 WBS Buy $40.81 760 $31,022.60  $194.85 $92,256.65 
 
Table 3.2-12 Week 9 Intrasector (Finance) Account 
 
 Active trading ended on July 27th, 2007.  All existing securities were sold by the 
end of the final trading day.  In the healthcare account, shares of AstraZeneca (696 shares 
sold at $53.07 for a 3.63% loss), Amgen (690 shares sold at $56.52 for a 1.76% gain), 
and Momenta Pharmaceuticals Inc (3,670 shares sold at $9.81 for a 5.80% loss) were 
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sold resulting in a net loss of 2.46% for the week.  In the finance account, shares of 
BankAtlantic Bancorp Inc (4,060 shares sold at $8.21 for an 8.41% gain), Franklin Bank 
Corp (2,300 shares sold at $11.66 for an 11.51% loss), and Webster Financial Corp (760 
shares sold at $43.46 for a 6.44% gain) were sold for a 1.52% gain on the week.  This 
concluded the trading portion of this project. 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $142.08 $114,991.38 
7/26/2007 AZN Sell $53.07 696 ($36,929.72) ($1,392.08) $37,071.80 $113,599.30 
7/26/2007 AMGN Sell $56.52 690 ($38,991.80) $676.00 $76,063.60 $114,275.30 
7/26/2007 MNTA Sell $9.81 3,670 ($35,995.70) ($2,216.00) $112,059.30 $112,059.30 
 
Table 3.2-13 Week 10 Healthcare Account 
 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
Start       $194.85 $92,256.65 
7/27/2007 BBX Sell $8.21 4,060 ($33,325.60) $2,584.40 $33,520.45 $94,841.05 
7/27/2007 FBTX Sell $11.66 2,300 ($26,811.00) ($3,487.00) $60,331.45 $91,354.05 
7/27/2007 WBS Sell $43.46 760 ($33,022.60) $2,000.00 $93,354.05 $93,354.05 
 
Table 3.2-14 Week 10 Intrasector (Finance) Account 
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3.3 Long Term Trading 
The long term mutual funds account set up the initial mutual funds during the week 
of June 7, 2007.  Franklin Balance Sheet Investment Adv (FBSAX) was purchased on 
6/7/2007 at 3:23:08 PM.  447 shares were purchased at $74.59 a share.  If past 
performance is any indication of future performance then this mutual fund stands at 
slightly beating the market.  BlackRock Equity Dividend A (MDDVX) was purchased on 
6/7/2007 at 3:22:23 PM.  1,650 shares were purchased at $20.14 a share.  Rainier Mid 
Cap Equity I (RAIMX) was purchased on 6/7/2007 at 3:21:24 PM.  776 shares were 
purchased at $42.94 a share. 
 The long term stock account also purchased its initial funds.  412 shares of 
Chevron Corporation (CVX), 404 shares of Exxon Mobil (XOM), and 251 shares of 
PetroChina (PTR) were purchased on 6/7/2007.  Their prices were $80.60, $82.37, and 
$132.86 respectively. 
Long term single stocks were “sold” using the closing cost on the last day of the 
project, July 27th, 2007.  Chevron Corporation (412 shares sold at $85.20 for a 5.66% 
gain), Exxon Mobile (404 shares sold at $85.59 for a 3.87% gain), and PetroChina (251 
shares sold at $147.34 for a 10.85% gain) were sold ending with a net gain across the 
project of 6.79%.  Long term mutual funds were sold using the same method.  Franklin 
Balance Sheet Investment Adv (447 shares sold at $68.57 for a 8.11% loss),BlackRock 
Equity Dividend A (1,650 shares sold at $19.49 for a 3.27% loss), and Rainier Mid Cap 
Equity I (776 shares sold at $42.61 for a 0.81% loss) were sold resulting in a 4.06% loss 
over the project.  This closes out all existing long term trading accounts. 
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Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
5/23/2007       $146.46 $100,000.00 
7/27/2007 CVX Sell $85.20 412 ($35,095.40) $1,881.20 $35,241.86 $101,881.20 
7/27/2007 XOM Sell $85.59 404 ($34,571.36) $1,286.88 $69,813.22 $103,168.08 
7/27/2007 PTR Sell $147.34 251 ($36,975.34) $3,620.48 $106,788.56 $106,788.56 
 
Table 3.3-1 Long Term Single Stock Trading 
 
 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
5/23/2007       $84.83 $100,000.00 
7/27/2007 FBSAX Sell $68.57 447 ($30,643.79) ($2,704.94) $30,728.62 $97,295.06 
7/27/2007 MDDVX Sell $19.49 1,650 ($32,151.50) ($1086.50) $62,880.12 $96,208.56 
7/27/2007 RAIMX Sell $42.61 776 ($33,058.36) ($270.08) $95,938.48 $95,938.48 
 
Table 3.3-2 Mutual Funds Trading 
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Chapter 4 Results 
Trading was concluded on July 27th, 2007.  All transactions for the shortterm 
accounts are summarized in the following two tables. 
Table 1 - Short Term Healthcare Account 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
5/23/2007         $100,000.00 $100,000.00  
6/7/2007 OSIR Buy $12.14 2,740 $33,270.60   $66,729.40 $100,000.00  
6/7/2007 CBM Buy $12.51 2,664 $33,333.64   $33,395.76 $100,000.00  
6/7/2007 BCRX Buy $7.78 4,282 $33,320.96   $74.80 $100,000.00  
6/13/2007 OSIR Sell $12.80 2,740 ($35,065.00) $1,794.40  $35,139.80 $101,794.40  
6/13/2007 EBS Buy $8.61 4,070 $35,049.70   $90.10 $101,794.40  
6/18/2007 EBS Sell $10.09 4,070 ($41,059.30) $6,009.60  $41,149.40 $107,804.00  
6/22/2007 CBM Sell $13.38 2,664 ($35,637.32) $2,303.68  $76,786.72 $110,107.68  
6/22/2007 DNA Buy $74.93 512 $38,371.16   $38,415.56 $110,107.68  
6/22/2007 AZN Buy $51.11 745 $38,083.95   $331.61 $110,107.68  
6/29/2007 AZN Sell $53.54 745 ($39,880.30) $1,796.35  $40,211.91 $111,904.03  
6/29/2007 DNA Sell $75.49 512 ($38,643.88) $272.72  $78,855.79 $112,176.75  
6/29/2007 SNY Buy $40.29 975 $39,289.75   $39,566.04 $112,176.75  
6/29/2007 ASPV Buy $17.12 2,300 $39,383.00   $183.04 $112,176.75  
7/6/2007 ASPV Sell $18.79 2,300 ($43,210.00) $3,827.00  $43,393.04 $116,003.75  
7/6/2007 BCRX Sell $7.82 4,282 ($33,478.24) $157.28  $76,871.28 $116,161.03  
7/6/2007 SNY Sell $41.82 975 ($40,767.50) $1,477.75  $117,638.78 $117,638.78  
7/6/2007 KERX Buy $9.81 3,993 $39,178.33   $78,460.45 $117,638.78  
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7/6/2007 TRMS Buy $6.54 5,979 $39,109.66   $39,350.79 $117,638.78  
7/6/2007 ZGEN Buy $14.19 2,760 $39,171.40   $179.39 $117,638.78  
7/13/2007 TRMS Sell $6.74 5,979 ($40,291.46) $1,181.80  $40,470.85 $118,820.58  
7/17/2007 KERX Sell $9.01 3,993 ($35,983.93) ($3,194.40) $76,454.78 $115,626.18 
7/17/2007 ZGEN Sell $13.96 2,760 ($38,536.60) ($634.80) $114,991.38 $114,991.38 
7/18/2007 AZN Buy $55.05 696 $38,321.80  $76669.58 $114,991.38 
7/18/2007 AMGN Buy $55.52 690 $38,315.80  $38353.78 $114,991.38 
7/18/2007 MNTA Buy $10.41 3,670 $38,211.70  $142.08 $114,991.38 
7/26/2007 AZN Sell $53.07 696 ($36,929.72) ($1,392.08) $37,071.80 $113,599.30 
7/26/2007 AMGN Sell $56.52 690 ($38,991.80) $676.00 $76,063.60 $114,275.30 
7/26/2007 MNTA Sell $9.81 3,670 ($35,995.70) ($2,216.00) $112,059.30 $112,059.30 
 
Table 2 - Short Term Intersector (Finance) Account 
Date Ticker 
Buy / 
Sell Price Shares 
Cost Basis / 
(Proceeds) 
Profit / 
(Loss) Total Cash Total Assets 
5/24/2007       $100,000.00  $100,000.00  
6/7/2007 IDIX Buy $7.10 7,040 $49,991.00  $50,009.00  $100,000.00  
6/7/2007 AFFY Buy $30.17 1,657 $49,998.69  $10.31  $100,000.00  
6/22/2007 AFFY Sell $28.14 1,657 ($46,620.98) ($3,377.71) $46,631.29  $96,622.29  
6/22/2007 IDIX Sell $6.18 7,040 ($43,500.20) ($6,490.80) $90,131.49  $90,131.49  
6/22/2007 IBKC Buy $49.87 602 $30,028.74  $60,102.75  $90,131.49  
6/22/2007 CBON Buy $28.17 1,066 $30,036.22  $30,066.53  $90,131.49  
6/22/2007 CTBI Buy $31.72 940 $29,823.80  $242.73  $90,131.49  
6/29/2007 CTBI Sell $32.95 940 ($30,966.00) $1,142.20 $31,208.73  $91,273.69  
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6/29/2007 CBON Sell $28.42 1,066 ($30,288.72) $252.50 $61,497.45  $91,526.19  
6/29/2007 AF Buy $25.09 1,220 $30,616.80  $30,880.65  $91,526.19  
6/29/2007 HBHC Buy $38.35 800 $30,687.00  $193.65  $91,526.19  
7/6/2007 AF Sell $25.34 1,220 ($30,907.80) $291.00 $31,101.45  $91,817.19  
7/6/2007 IBKC Sell $49.95 602 ($30,062.90) $34.16 $61,164.35  $91,851.35  
7/6/2007 HCBK Buy $12.24 2,495 $30,545.80  $30,618.55  $91,851.35  
7/6/2007 VCBI Buy $16.33 1,865 $30,462.45  $156.10  $91,851.35  
7/18/2007 VCBI Sell $17.00 1,865 ($31,712.00) $1,249.55 $31,868.10 $93,100.90 
7/19/2007 HBHC Sell $39.01 800 ($31,215.00) $528.00 $63,083.10 $93,628.90 
7/19/2007 HCBK Sell $11.69 2,495 ($29,173.55) ($1,372.25) $92,256.65 $92,256.65 
7/20/2007 BBX Buy $7.57 4,060 $30,741.20  $61,515.45 $92,256.65 
7/20/2007 FBTX Buy $13.17 2,300 $30,298.00  $31,217.45 $92,256.65 
7/20/2007 WBS Buy $40.81 760 $31,022.60  $194.85 $92,256.65 
7/27/2007 BBX Sell $8.21 4,060 ($33,325.60) $2,584.40 $33,520.45 $94,841.05 
7/27/2007 FBTX Sell $11.66 2,300 ($26,811.00) ($3,487.00) $60,331.45 $91,354.05 
7/27/2007 WBS Sell $43.46 760 ($33,022.60) $2,000.00 $93,354.05 $93,354.05 
 Any other open investments were liquidated at July 27th's closing price.  The 
results were tallied in the table below: 
 Start Finish % Gain 
Healthcare (short) $100,000.00 $112,031.30 12.03% 
Financial (short) $100,000.00 $93,312.05 -6.69% 
Energy (long) $100,000.00 $106,788.56 6.79% 
Mutual Funds $100,000.00 $95,938.48 -4.06% 
S&P Index $100,000.00 $95,598.20 -4.40% 
Treasury (bonds) $100,000.00 $100,870.77 0.87% 
Table 3.3-1 Final Results Table 
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As can be seen, the short term healthcare and long term single stock accounts 
performed the best.  The next best performer was expectedly the least risky investment of 
all, the US Treasury Bonds.  The short term financial, mutual funds, and the index fund 
all closed with a loss.  The final result is somewhat misleading, as several of these groups 
took a dip right before the completion of this project.  It is the belief of the tester that 
these were only momentary drops resulting from a further decline housing sector, and 
that the market would have corrected itself in the following week.  This is illustrated in 
the following chart: 
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Chart 3.3-2 Day By Day Account Values 
 Clearly the mutual funds, index fund, and even the energy stocks were heavily 
affected by the market during the final week.  Interesting enough, the S&P index fund at 
its highest point barely produced a profit over this time frame.  In percentage terms, the 
healthcare account outperformed the treasury account by 11.16% and the S&P index fund 
by 16.43%.  The finance account underperformed the treasury account by 7.56% and the 
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S&P index fund by 2.29%.  The long term energy account outperformed them by 5.92% 
and 11.19%.  And the mutual funds account underperformed the treasury account by 
4.93% and outperformed the S&P fund by 0.34%.   
 From these results the Healthcare account method was definitively the superior 
investment method.  At an annualized rate, the Healthcare account would gain 48% while 
the Finance account would lose 27%.  The selection of the down trodden Healthcare 
industry was successfully entered as stocks were beginning to rebound.  Furthermore, the 
relatively quick hopping allowed gains to be realized from several different stocks, and 
the analysis to find the stocks within 10% of their one year lows helped isolate the next 
stock to jump.  The exact opposite was realized with the finance account.  With the 
mortgage market pulling the whole industry to new lows, selected stocks were often not 
about to enter a period of recovery.  The result was the ability to pick a new set of 
“losers” and resulting in the worst performance of any account.   
 Long term investments are somewhat harder to ascertain.  The initial prediction 
was that oil stocks would do well during the summer months, and this appears fairly 
accurate.  It appears that some past trends can be used to predict future performance.  
Mutual funds were also close to what was predicted.  They stayed very close with the 
market, slightly outperforming it throughout the project.  The association with many 
stocks within the mutual funds does seem to limit the growth from the biotech group and 
the losses from the finance group.  
The market itself did not do very well during this time period, spending 26 of 46 
trading days below the starting point.  This is very surprising, as the market average is 
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expected to rise anywhere between seven and ten percent annually.  To have a decline 
during 25% of the available trading days that this project represents means that the 
market has to perform even higher to reach that seven percent baseline.  All this leads to 
the idea that the market will perform worse this year than it has during the past 5 years.  
Furthermore, during the time period of this project the market was very erratic in terms of 
great gains and great losses.  The best description would define the time as uneasy in 
terms of investor confidence.  On a side note, the US Treasury Bonds definitely gave a 
less stressful experience.  While they did beat the market average during this short term 
test, it is fairly certain that it will under perform the market in the long run. 
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Chapter 5 Conclusion 
In the end all the goals of the project were met.  Initial research was performed 
and familiarity with company financials was gained.  Research online, in news, and in 
print were initiated and continued throughout the project.  Evaluations of company SEC 
filings were performed, examination of earnings per share was utilized, and sector wide 
trends were created.  Concepts such as EBTIDA and market capitalization were 
examined to locate key stocks.  And final analysis of the investment styles was 
completed.   
The final conclusions are somewhat mixed.  Biotechnology stocks which had 
taken a hit and were expected to recover, did in fact recover.  Market research appeared 
to be able to point out these companies with reasonable accuracy.  Energy stocks did 
increase in value over this time period as well, which lends some credence to the idea that 
we use more gasoline during these summer months.  However, many online investment 
sites predict that index funds will perform most reliably over the long term, yet 
information gathered from this study seems to point in a different direction.  It should be 
noted that true decisions on these matters cannot be completely rendered as this was a 
short term project. 
What is apparent is that troubles in some industries, namely the housing market, 
can quickly pull down the entire market.  During the time frame of this project we had 
troubles with Ford, the selling of Chrysler, American Home Mortgages declaring 
bankruptcy, and an increase in subprime mortgages defaulting.  At the same time, we had 
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record profits from Amazon, the release of the much anticipated iPhone, and the bid for 
the Wall Street Journal by Rupert Murdoch.  Foreign markets also affected the US as was 
seen by the market correction in China.  In connection with this short term investment 
strategies appear to be all about timing.  The healthcare account took advantage of a 
market recovery.  The finance account got taken advantage by a market failure.  There 
were no differences in their investment styles.  Both looked for profitable, low to mid cap 
companies who were at a low relative stock price.  Many of them had recently announced 
bad news.  Yet the healthcare account performed astoundingly, and the finance account 
tanked.  This best describes the hit or miss mentality of single stock investing.   
One research concept that was proven was the determination of one's own 
personal ability to deal with the security of one's investments.  Day to day balance 
changes in the short term accounts caused much more stress than the completely stress 
free US Treasury bonds.  Anyone who doesn’t want to obsess and watch over a stock 
daily (or minute to minute) certainly should not become a day trader.  However, there 
appears to be a definite bonus to having more interaction than the buy-it-and-forget-it 
mentality of bonds, as bonds are often considered a bottom baseline.  Mutual funds 
represent a mix in terms of risk and could be purchased and forgotten, at least for a few 
months.  That feeling of security doesn’t seem to exist for any single stock investment 
style.  And mutual funds appear to perform around the market average to boot.  This 
gives some insight into the popularity of mutual funds.  Finally, single stocks investors 
should not be careless and carefree.  The consequences are apparent with American 
Home Mortgage losing 52% of its value in one day, and 97.7% year to date as of the 
beginning of August.  Overall, finding your level of resilience to gains and losses seems 
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to be one of the best first steps towards investing with your own money.  After all, if you 
worry yourself into an early grave, what benefit does having a fortune in the market serve 
you?
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Figures 
Figure 2.3.1 Emergent BioSolutions Technical Chart May 23 2007 to Present.  5 June 
2007 <http://finance.yahoo.com/q/bc?s=EBS&t=1y&l=on&z=m&q=l&c=> 
 
Figure 2.3-2 AstraZeneca 1 Year Technical Chart.  5 June 2007 
<http://finance.yahoo.com/q/bc?s=AZN&t=1y&l=on&z=m&q=l&c=> 
 
Figure 2.3-3 Astoria Financial 5 Day Chart 5 July 2007 
<http://finance.yahoo.com/charts#chart2:symbol=aspv;range=5d;compare=sny;> 
 
Figure 2.3-4 Virginia Commerce Bancorp 1 Year Chart 8 July 2007 
<http://finance.yahoo.com/q/bc?s=VCBI&t=1y&l=on&z=m&q=l&c=> 
 
Figure 2.3-5 Hudson City Bancorp Inc 1 Year Chart 8 July 2007 
<http://finance.yahoo.com/q/bc?s=HCBK&t=1y&l=on&z=m&q=l&c=> 
 
Figure 2.3-6 ZymoGenetics 1 Year Chart 8 July 2007 
<http://finance.yahoo.com/q/bc?s=ZGEN&t=1y&l=on&z=m&q=l&c=> 
 
Figure 3.2-1 IberiaBank Corp Chart 5 July 2007 
<http://finance.yahoo.com/q/bc?s=IBKC&t=1d> 
 
Figure 3.2-2 Aspreva & Sanofi-Aventis 1 Week Gains 5 July 2007 
<http://finance.yahoo.com/q/bc?s=IBKC&t=1d> 
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Appendix 
Time Table 
Week Activity 
1st (May 21st – May 27th) Write initial project, perform beginning research.  
S&P stock and Treasury Bills “purchased” 
2nd (May 28th – June 3rd) Basic investment research and glossary complete.  
First stocks selected and purchased.   
3rd (June 4th – June 10th) 2-3 stocks traded per week for short term accounts 
4th (June 11th – June 17th) 2-3 stocks traded per week for short term accounts 
5th (June 18th – June 26th) 2-3 stocks traded per week for short term accounts 
6th (June 27th – July 1st) 2-3 stocks traded per week for short term accounts 
7th (July 2nd – July 8th) 2-3 stocks traded per week for short term accounts 
8th (July 9th – July 15th) 2-3 stocks traded per week for short term accounts 
9th (July 16th – July 22nd) 2-3 stocks traded per week for short term accounts 
10th (July 23rd – July 29th) Investment portion complete.  Project wrap up begins 
11th (July 30th – August 5th) Project wrap up complete.  Final report submitted 
12th (August 6th – August 12th) Additional time used as required 
13th (August 13th – August 19th) Additional time used as required 
 65
Glossary 
Asset - are anything that have value.  Your house, car, checking account, and the 
antique china set your grandma gave you are all assets.  Companies figure 
up the dollar value of everything they own and put it under the asset side of 
the balance sheet. 
Bond - A loan given by you to another entity 
Consumer Confidence Index (CCI) - The consumer confidence index is released each 
month by the Conference Board, an independent business research organization. 
It measures how a representative sample of 5,000 US households feel about the 
current state of the economy, and what they anticipate the future will bring. The 
survey focuses specifically on the participants’ impressions of business 
conditions and the job market.  Economic observers follow the index because 
when consumer attitudes are positive they are more likely to spend money, 
contributing to the very economic growth they anticipate. But if consumers are 
worried about their jobs, they may spend less, contributing to an economic 
slowdown. 
Discounted Operations - Profit or loss in an Income Statement from a group which won't 
be part of the company for very much longer 
Goodwill - can be thought of as a "premium" for buying a business.  When one company 
buys another, the amount they pay is called the purchase price.  Accountants 
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take the purchase price and subtract it by a company's book value.  The 
difference is called Goodwill. 
Liabilties - are the opposite of assets.  They are anything that cost a company money.  
Liabilities include monthly rent payments, utility bills, the mortgage on the 
building, corporate credit card debt, and any bonds the company has issued. 
Limit Order – A market order to buy or sell a stock once it hits a certain price 
Liquidity - How easy it is to turn an asset into cash 
Market Order - An order to buy or sell a security at the current market price 
Profitable Borrowing - When a business can earn a higher rate of return than the interest 
rate at which it borrows, it becomes profitable for the business to borrow 
money. 
Proprietorship Reserves - An amount of money set aside for a specific purpose such as 
purchasing a new factory.   
Retained Earnings - the accumulated profits a business has held on to and not paid out to 
its shareholders as dividends. 
Security - An instrument that signifies an ownership position in a corporation (a stock), a 
creditor relationship with a corporation or governmental body (a bond), or rights 
to ownership such as those represented by an option. 
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Shareholder Equity - Tthe difference between assets and liability; it tells you the 
"book value", or what is left for the stockholders after all the debt has been 
paid. 
Spread – Difference between the buy and sell share price of a stock.  The spread is the fee 
that the exchange takes for organizing the trade between the buyers and sellers.  
Some stocks are not as liquid as other stocks and the order must be held for a 
longer time, increasing the risk that the stock cannot be sold.  The end result is 
that the exchange charges a larger fee depending on the liquidity of a stock. 
Stock -  A representation of partial ownership of a company 
Stop Loss Order – A market order to sell a stock if it falls below a certain price.  Stop 
loss orders are used as a form of insurance to prevent a large loss. 
Subsidiary - Is a company controlled by another company through ownership of at least a 
majority of the voting stock 
Trailing Stop - A market order similar to a Stop Loss to protect profit on a security. 
